Yesterday's announced financings: April 26

Here’s your roundup of yesterday's announced equity financings, courtesy of PrivatePlacements.com: the only database that tracks every financing, every day.

1. RevoluGROUP Canada Inc. (TSX-V: REVO)

• Gross Proceeds: $12.47 million
• Sector: Banking
• Units issued: 43 million
• Type: Special units
• Price: $0.29
• Warrants: Full; $0.40; One year
• Agents: Non-brokered
• Use of Proceeds: Business development

Company breakdown:

• Licensed banker that can trade cryptocurrency and store crypto assets
• Flagship tech is RevoluPAY, a payment app and linked Visa card
• Recently were forced to suspend ongoing equity investment negotiations with a "suitor" due to an untenable workload for its CEO

2.  Japan Gold Corp. (TSX-V: JG)

• Gross Proceeds: $10 million
• Sector: Precious metals
• Units issued: 50 million
• Type: Common shares
• Price: $0.20
• Warrants: None
• Agents: Non-brokered
• Use of Proceeds: Ongoing exploration

Company breakdown:

• Junior miner focused entirely on projects in Japan
• Has a countrywide strategic alliance with Barrick
• Six projects in Japan

3. Rivalry Corp. (TSX-V: RVLY)

• Gross Proceeds: $10 million
• Sector: Sports betting
• Units issued: 6.67 million
• Type: Subordinate voting shares
• Price: $1.50
• Warrants: None
• Agents: Pinnacle
• Use of Proceeds: Not stated

Company breakdown:

• Sports betting company focused on esports in addition to traditional gambling
• Company lose $31.1 million in 2022

4. Goliath Resources Ltd. (TSX-V: GOT)

• Gross Proceeds: $8 million
• Sector: Precious metals
• Units issued: 8 million
• Type: Flow-through shares
• Price: $1.00
• Warrants:  Half; $0.92; Two years
• Agents: Red Cloud Securities
• Use of Proceeds: Ongoing exploration

Company breakdown:

• Junior miner with the Golddigger project in the Golden Triangle of British Columbia
• Recently released petrographic study results for the project, and drilled 11 metres of 13.53 g/t AuEq

5. Awakn Life Sciences Corp. (NEO: AWKN)

• Gross Proceeds: $3 million
• Sector: Psychedelic therapeutics
• Units issued: 6.52 million
• Type: Special units
• Price: $0.46
• Warrants:  Three-quarters; $0.63; Five years
• Agents: Non-brokered
• Use of Proceeds: Not stated

Company breakdown:

• Developing psychedelic therapeutics to treat alcohol use disorder
• Signed an agreement with the University of Exeter for a phase III trial exploring the use of ketamine-assisted therapy to treat alcohol use disorder